Abstract

BackgroundCarotid artery stenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy (CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and anatomical predictive factors for in-stent restenosis.MethodsWe performed a retrospective monocentric study. We included all patients who underwent CAS for post-CEA restenosis at our institution from July 1997 to November 2013. The primary endpoints were the technical success, the presence of in-stent restenosis >50% or occlusion, either symptomatic or asymptomatic, during the follow-up period, and risk factors for restenosis. The secondary endpoints were early and late morbidity and mortality (TIA, stroke, myocardial infarction, or death).ResultsA total of 153 CAS procedures were performed for post-CEA restenosis, primarily because of asymptomatic lesions (137/153). The technical success rate was 98%. The 30-day perioperative stroke and death rate was 2.6% (two TIAs and two minor strokes), and rates of 2.2% (3/137) and 6.2% (1/16) were recorded for asymptomatic and symptomatic patients, respectively. The average follow-up time was 36 months (range, 6–171 months). In-stent restenosis or occlusion was observed in 16 patients (10.6%). Symptomatic restenosis was observed in only one patient. We found that young age (P = 0.002), stenosis > 85% (P = 0.018), and a lack of stent coverage of the common carotid artery (P = 0.006) were independent predictors of in-stent restenosis.ConclusionWe identified new risk factors for in-stent restenosis that were specific to this population, and we propose a technical approach that may reduce this risk.

Highlights

  • The incidence of restenosis after carotid surgery varies from 1% to 36% [1,2,3], depending on the definition of restenosis and the length of follow-up

  • A total of 153 carotid angioplasty/stenting (CAS) procedures were performed for post-carotid endarterectomy (CEA) restenosis, primarily because of asymptomatic lesions (137/153)

  • We identified new risk factors for in-stent restenosis that were specific to this population, and we propose a technical approach that may reduce this risk

Read more

Summary

Introduction

The incidence of restenosis after carotid surgery varies from 1% to 36% [1,2,3], depending on the definition of restenosis and the length of follow-up. Redo carotid surgery is technically difficult and usually complicated by cranial nerve injury. The incidence of cranial nerve injuries has been reported to range from 1% to 17%, and studies show that most such reported injuries are transient. Many studies have compared CAS to redo surgery [5,6,7, 10,11,12]. Endovascular treatment provides an advantage in that it reduces the risk of cranial nerve injury [5]. Carotid artery stenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy (CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and anatomical predictive factors for in-stent restenosis

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call